Valuation : Profarma Distribuidora de Produtos Farmacêuticos S.A.

Market Cap 94Cr 18Cr 16Cr 15Cr 14Cr 25Cr 1.74TCr 26Cr 175.97Cr 69Cr 890Cr 69Cr 68Cr 2.87TCr P/E 2024
6.95x
P/E 2025 9.42x
Enterprise Value 210.71Cr 41Cr 36Cr 33Cr 30Cr 57Cr 3.9TCr 57Cr 394.27Cr 153.54Cr 1.99TCr 155.01Cr 151.63Cr 6.42TCr EV / Sales 2024
0.18x
EV / Sales 2025 0.2x
Free-Float
32.86%
Yield 2024
8.86%
Yield 2025 -
30/07 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
07/05 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
16/03 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 CI
03/03 Brazil's Profarma to buy 4Bio from Raia Drogasil in 600 mln reais deal RE
05/11 Bmk, Bpl negotiate potential acquisition of Bpl shares in Brazil's Profarma RE
30/25/30 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
31/25/31 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
05/25/05 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
19/25/19 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 CI
19/25/19 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
31/24/31 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
07/24/07 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
08/24/08 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
1 day+7.77%
1 week+1.73%
Current month+2.42%
1 month+8.84%
3 months+14.22%
6 months-15.69%
Current year-16.43%
1 week 7.3
Extreme 7.3
7.85
1 month 6.66
Extreme 6.66
7.85
Current year 6.11
Extreme 6.11
9.7
1 year 6.11
Extreme 6.11
9.7
3 years 3.4
Extreme 3.4
9.7
5 years 2.92
Extreme 2.92
9.7
10 years 2.87
Extreme 2.87
11.79
Manager TitleAgeSince
Chief Executive Officer 58 21/04/2010
Director of Finance/CFO 68 01/01/1993
Director TitleAgeSince
Chairman 58 03/04/2008
Director/Board Member 91 21/04/2010
Director/Board Member 62 21/04/2010
Date Insider Type Main position Quantity % Market Cap. Importance
08/08/25 Others 1 0.0000% -
09/12/24 Sell 12,200 0.0099%
09/12/24 Sell 12,400 0.0100%
Change 5-day change 1-year change 3-year change Capi.($)
+7.77%+1.73%-4.98%+104.56% 18Cr
-0.33%+2.74%+32.75%+125.46% 11TCr
-0.54%+5.95%+66.40%+185.93% 5.78TCr
+0.37%+0.75%-10.89%+241.77% 2.23TCr
+0.55%+1.04%-11.04%-7.85% 816.06Cr
+1.22%-0.79%-39.05%-28.02% 716.67Cr
-0.72%+6.23%+4.66%+25.07% 682.8Cr
+1.49%-1.51%-14.77%-31.78% 615.36Cr
+0.15%-1.36%-5.83%+20.32% 512.8Cr
+3.00%+8.11%+311.90%+497.01% 449.92Cr
Average +1.26%+2.34%+32.91%+113.25% 2.26TCr
Weighted average by Cap. -0.11%+2.92%+35.71%+140.41%

Financials

2024 2025
Net sales 1.02TCr 198.91Cr 171.14Cr 160.6Cr 146.94Cr 274.25Cr 19TCr 276.43Cr 1.9TCr 739.89Cr 9.61TCr 746.95Cr 730.66Cr 31TCr 1.15TCr 224.32Cr 193Cr 181.12Cr 165.71Cr 309.28Cr 21TCr 311.73Cr 2.14TCr 834.39Cr 11TCr 842.36Cr 823.99Cr 35TCr
Net income 11Cr 2.24Cr 1.93Cr 1.81Cr 1.66Cr 3.09Cr 212.19Cr 3.12Cr 21Cr 8.35Cr 108.44Cr 8.43Cr 8.25Cr 349.23Cr 12Cr 2.33Cr 2Cr 1.88Cr 1.72Cr 3.21Cr 220.18Cr 3.24Cr 22Cr 8.66Cr 112.52Cr 8.75Cr 8.56Cr 362.39Cr
Net Debt 101.72Cr 20Cr 17Cr 16Cr 15Cr 27Cr 1.88TCr 28Cr 190.32Cr 74Cr 962.62Cr 75Cr 73Cr 3.1TCr 116.67Cr 23Cr 20Cr 18Cr 17Cr 32Cr 2.16TCr 32Cr 218.3Cr 85Cr 1.1TCr 86Cr 84Cr 3.56TCr
Logo Profarma Distribuidora de Produtos Farmacêuticos S.A.
Profarma Distribuidora de Produtos Farmaceuticos SA is a Brazil-based company primarily engaged in the wholesale trading of drugs. The Company's activities are divided into two segments: Pharmaceutical Distribution and Retail. The Pharmaceutical Distribution division is responsible for the wholesale of medicines and personal care and beauty products to pharmaceutical retailers. The Retail division focuses on the management of a pharmacies network under a number of brand names, such as Drogasmil and Tamoio. Its products range includes prescription drugs, over-the-counter (OTC) generics, personal hygiene articles and cosmetics, vaccines, dermatological products and hospital pharmaceuticals, among others. The Company's subsidiaries include Farmadacta Informatica Ltda, Promovendas Representacoes Ltda, Interagile Propaganda e Promocoes Ltda and Locafarma Solucoes de Transportes e Logistica Ltda, among others.
Employees
7,077
Date Price Change Volume
04/26/04 R$7.630 +7.77% 3,200
03/26/03 R$7.670 -0.52% 1,32,600
02/26/02 R$7.710 +3.21% 2,67,100
01/26/01 R$7.470 +0.27% 1,31,500
31/26/31 R$7.450 -0.67% 1,83,200
  1. Stock Market
  2. Stocks
  3. PFRM3 Stock